News Conference News THT 2026 Baroreflex Activation for Advanced HF Yields Positive Results: Postmarketing Data Even as BAT expands beyond trial criteria, patients see gains in LVEF, symptoms, and more. A survival impact remains unclear. Todd Neale March 05, 2026
Presentation THT Abstracts 2026 High Risk PCI with Hemodynamic Optimization Peri-revascularization (HiHO) Presenter: Jared Romeo March 03, 2026
Presentation THT Abstracts 2026 Impact of Pulmonary Hypertension Subtypes on Clinical Outcomes and Resource Utilization in Heart Failure Presenter: Bryce Allen March 03, 2026
Presentation THT Abstracts 2026 Potassium Levels and In-Hospital Mortality in Acute Heart Failure Presenter: Aarjuv Majmundar March 03, 2026
Presentation THT Abstracts 2026 Real-World Adherence to CardioMEMS Transmissions and Associations with Clinical Outcomes Presenter: Sirish Vullaganti March 03, 2026
Presentation THT Abstracts 2026 The Impact of Aortic Stenosis on the Obesity Paradox in Acute Decompensated Heart Failure Presenter: Bryce Allen March 03, 2026
News Conference News THT 2026 AI for Heart Failure Care Is Evolving Rapidly, THT 2026 Makes Clear By Todd Neale March 10, 2026
News Conference News THT 2026 Should Moderate FMR Be Treated With M-TEER? Experts Duke It Out By Todd Neale March 06, 2026
News Daily News Advanced HF in Finland: Costs, Survival Diverge for Elective vs Urgent LVAD By Caitlin E. Cox March 06, 2026
News Conference News THT 2026 Baroreflex Activation for Advanced HF Yields Positive Results: Postmarketing Data By Todd Neale March 05, 2026
News Conference News THT 2026 Optimal BP After HeartMate 3 LVAD May Be Higher Than Previously Thought By Todd Neale March 04, 2026